My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Cipla gets healthier after receiving final USFDA approval for generic drug
Dec 08,2016

The announcement was made during market hours today, 8 December 2016.

Meanwhile, the S&P BSE Sensex was up 378.42 points or 1.44% at 26,615.29.

On the BSE, 63,186 shares were traded in the counter so far as against average daily volume of 1.57 lakh shares in the past one quarter. The stock had hit a high of Rs 578.60 and a low of Rs 571 so far during the day. The stock had hit a 52-week high of Rs 660 on 29 December 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016.

The stock had outperformed the market over the past one month till 7 December 2016, gaining 4.52% compared with the Sensexs 4.45% fall. The scrip had also outperformed the market in past one quarter, declining 1.78% as against the Sensexs 9.3% fall.

The large-cap company has equity capital of Rs 160.85 crore. Face value per share is Rs 2.

Cipla announced that it received final approval for its abbreviated new drug application (ANDA) for Entecavir Tablets USP 0.5 mg and 1 mg, from the United States Food and Drug Administration (USFDA).

Entecavir Tablets, USP 0.5 mg and 1 mg, are AB-rated generic equivalents of Bristol-Myers Squibbs Baraclude tablets 0.5 mg and 1 mg and are a Hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic Hepatitis B virus infection.

Baraclude Tablets and generic equivalents had annual US sales of approximately $206 million for the 12 month period ending October 2016, according to IMS Health. The product will cater to the US market and will be commercially available in the coming weeks.

On a consolidated basis, Ciplas net profit dropped 34.7% to Rs 354.34 crore on 8.7% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company.

Powered by Capital Market - Live News

PVP Ventures announces resignation of company secretary
Dec 08,2016

PVP Ventures announced that V. Ravi Kumar Reddy, Company Secretary and Compliance Officer has resigned from the Company effective from the closing hours of 07 December 2016.

Powered by Capital Market - Live News

Jaguar Land Rover announces sales figures
Dec 08,2016

Jaguar Land Rover, the UKs leading manufacturer of premium luxury vehicles, reported its best ever November retail sales of 47,588 vehicles, up 2% compared to November 2015.

The year-on-year growth in retail volumes was driven by strong sales of the new Jaguar XF (with the addition of the long wheel base XFL in China) and F-PACE as well as continuing solid sales of the Land Rover Discovery Sport and Range Rover Sport, offset partially by the run-out of Land RoverDiscovery in advance of the all-new model in 2017.

Jaguar Land Rover delivered solid retail sales growth across the majority of key regions for November year on year, with China (up 42%) and North America (up 20%) partially offset by softer sales in theUK (down 13%), Europe (down 6%) and in other overseas markets, which include Russia and Brazil (down 25%). Jaguar Land Rover sold 527,937 vehicles in the first 11 months of 2016, 21% up on thesame period in the prior year.

Jaguar recorded its best November ever, with retail sales reaching 14,613 vehicles, up 83% compared to November last year, and driven by continuing strong sales of the new XF and the F-PACE. Calendar year-to-date sales for Jaguar were 132,381, up 75% year-on-year.

Land Rover recorded November sales of 32,975 vehicles, down 14% on November 2015, as continuing solid sales of the Land Rover Discovery Sport and Range Rover Sport were offset by lower volumes of the discontinued Land Rover Defender and outgoing Discovery. Calendar year-to-date sales for Land Rover reached 395,556 vehicles, 9% up on the prior year.

Powered by Capital Market - Live News

Escorts shifts gears after compIeting divestment of auto products biz
Dec 08,2016

The announcement was made after market hours yesterday, 7 December 2016.

Meanwhile, the S&P BSE Sensex was up 389.57 points or 1.48% at 26,626.44.

On the BSE, 90,000 shares were traded on the counter so far as against the average daily volumes of 3.79 lakh shares in the past one quarter. The stock had hit a high of Rs 329.45 and a low of Rs 322 so far during the day.

The stock had hit a record high of Rs 414.20 on 4 October 2016 and a 52-week low of Rs 112.70 on 12 February 2016. It had underperformed the market over the past one month till 7 December 2016, sliding 10.56% compared with the Sensexs 4.45% fall. The scrip had, however, outperformed the market in the past one quarter, declining 5.23% as against the Sensexs 9.3% fall.

The mid-cap company has equity capital of Rs 122.58 crore. Face value per share is Rs 10.

Escorts had in August 2016, announced the divestment of its original equipment manufacturing (OEM) & export business of auto product division to Badve Engineering, Pune, in an all cash deal, as part of the planned strategic reorientation of the business to focus on core verticals in the agri machinery, construction equipment and railway equipment.

Net profit of Escorts rose 219.6% to Rs 31.29 crore on 21.7% rise in net sales to Rs 990.99 crore in Q2 September 2016 over Q2 September 2015.

Escorts is one of Indias leading engineering conglomerates. The company has diversified business interests catering to agri machinery, construction equipment and railway equipment divisions.

Powered by Capital Market - Live News

Cabinet approves MoU between India and United Kingdom (UK) to support Ease of Doing Business in India
Dec 08,2016

The Union Cabinet chaired by the Prime Minister Shri Narendra Modi has given its ex-post facto approval to the MoU between India and United Kingdom (UK) to support Ease of Doing Business in India. The MoU was signed earlier this month.

The MoU shall enable exchange of officials from both the Governments to facilitate sharing of best practises, offering technical assistance and enhanced implementation of reforms. The collaboration shall also cover State Governments in its ambit. The UK government has shown interest to offer expertise in the following areas:

a) Support to small businesses and start ups

b) Starting business and registration

c) Paying taxes and tax administration

d) Insolvency

e) Construction permits

f) Getting electricity

g) Risk based framework for inspection and regulatory regimes

h) Trading across the borders

i) Competition economics

j) Getting credit

k) Drafting of laws and regulations

I) Reducing stock and flow of regulation

m) Impact assessment of regulations

Currently, India is ranked 130th out of 190 economies (as per Doing Business Report, 2017). The UK Government has achieved phenomenal improvement in Ease of Doing Business (EoDB) rankings in recent years. The beneficiaries include the officials from Central Government Ministries / Departments and State Governments through sharing of best practises, capacity building etc. Each side shall bear the cost of travel and logistics for its officials as well as for co-hosting trainings/ seminar/conferences.

The MoU shall facilitate various agencies of the UK government to offer professional courses on better regulation drafting for officials, capacity-building of frontline inspectors, sharing of best practises, etc. The collaboration is expected to expedite adoption of innovative practises by the Government of India, State Governments and their agencies leading to easing of regulatory environment in the country and fostering of conducive business climate in India.

Powered by Capital Market - Live News

Ducon Infratechnologies secures contract with Wienerberger India
Dec 08,2016

Ducon Technologies India (DTIPL), a Ducon Inc. group company underamalgamation with Ducon Infratechnologies announced its contractwith Wienerberger India. Wienerberger is a wholly owned subsidiary Wienerberger AG -the worlds largest producer of ceramic building products.

Wienerberger currently uses pet coke as its fuel for its Karnataka plant, and it has decided to control Suspended Particulate Matter (SPM) & Sulphur Dioxide (SO2) emanating from its plant to comply with thepresent emission norms.

As per the terms of the contract, DTIPL will install Ducons proprietary Dry FGD(Flue Gas Desulfurization) systems to remove SPM and other toxic components as to enable this transition. DTIPL has alreadycommenced the engineering process and is expected to establish this facility within the contractual execution period which is in FY17.

Powered by Capital Market - Live News

Cipla receives ANDA approval for generic Baracluden++ tablets
Dec 08,2016

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Entecavir Tablets USP 0.5 mg and 1 mg, from the United States Food and Drug Administration (USFDA).

Entecavir Tablets, USP 0.5 mg and 1 mg, are AB-rated generic equivalents of Bristol-Myers Squibbs Baracluden++ tablets 0.5 mg and 1 mg and are a Hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic Hepatitis B virus infection.

Baracluden++ Tablets and generic equivalents had U.S. sales of approximately $206M for the 12 month period ending October 2016, according to IMS Health. The product will cater to the USmarket and will be commercially available in the coming weeks.

Powered by Capital Market - Live News

Board of Rane (Madras) to consider December Q3 and 9M results
Dec 08,2016

Rane (Madras) announced that a meeting of the board of directors of the Company has been scheduled to be held on 23 January 2017 to consider and approve the Unaudited Financial Results (Standalone) for the quarter and nine months ending 31 December 2016.

Powered by Capital Market - Live News

Rane Brake Lining to consider December quarter and 9M results
Dec 08,2016

Rane Brake Lining announced that a meeting of the board of directors of the Company has been scheduled to be held on 20 January 2017 to consider and approve the Unaudited Financial Results for the quarter and nine months ending 31 December 2016.

Powered by Capital Market - Live News

Cabinet approves MoU between India and United Kingdom (UK) for Cooperation in the Field of Intellectual Property
Dec 08,2016

The Union Cabinet chaired by the Prime Minister Shri Narendra Modi has given its ex-post facto approval to the MoU between India and United Kingdom (UK) for Cooperation in the Field of Intellectual Property (IP). The MoU was signed on 7 November 2016.

The MoU seeks to establish a wide-ranging and flexible mechanism for developing and furthering the cooperation in the development of automation, new documentation and information systems in IP. It provides an opportunity for collaboration in training programmes, exchange of experts and technical exchanges and outreach activities.

Implementation of the MoU will result in enhancement of the capacity of the Office of Controller General of Patents, Designs & Trademarks to examine patent applications, which in turn will impact innovation positively.

Powered by Capital Market - Live News

Rane Engine Valve to announce December quarter results
Dec 08,2016

Rane Engine Valve announced that a meeting of the board of directors of the Company has been scheduled to be held on 25 January 2017 to consider and approve the Unaudited Financial Results for the quarter and nine months ending 31 December 2016.

Powered by Capital Market - Live News

Indosolar to hold EGM
Dec 08,2016

Indosolar announced that the Extra Ordinary General Meeting (EGM) of the Company will be held on 30 December 2016.

Powered by Capital Market - Live News

Gujarat Industries Power Co commissions two WTGs of 1.5 MW each
Dec 08,2016

Gujarat Industries Power Co announced that two more wind turbine generators of 1.5 MW each have been commissioned by the Company at Village Kotadapitha, Taluka Babra, Dist. Amreli, Gujarat. Gujarat Energy Development Agency has issued certificate of commissioning of the said WTGs.

With the Commissioning of two WTGs, the Company has now commissioned 15 MW (10 x 1.5MW) Wind Mills at Kotadapitha Site.

Powered by Capital Market - Live News

Board of Western India Shipyard to consider preferential issue of shares and warrants
Dec 08,2016

Western India Shipyard announced that the Meeting of the Board of Directors of the Company is scheduled to be held on 09 December 2016, inter alia, to consider the proposal for preferential issue of equity shares and warrants to a new investor and any other business with permission of the Chairman.

Powered by Capital Market - Live News

Dynavisio provides update on lease agreement
Dec 08,2016

Dynavision announced that as per Lease Agreement dated 04 May 2012 entered with Apollo Hospitals Enterprise, the Lease Rent receivable stands increased from Rs. 38,75,000/- to Rs. 44,36,900/- per month. Thus an increase of Rs. 5,61,900/- per month effective from December 2016.

Powered by Capital Market - Live News